James Vollins
Compliance Officer bei EIGER BIOPHARMACEUTICALS, INC.
Vermögen: - $ am 31.03.2024
Profil
James A.
Vollins is currently the Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. Prior to this, he held the same position at BioDelivery Sciences International, Inc. from 2018 to 2022 and at Bio Products Laboratory Ltd.
from 2014 to 2018.
Vollins received his undergraduate degree from Wesleyan University and his graduate degree from Case Western Reserve University School of Law.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.04.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von James Vollins
Unternehmen | Position | Beginn |
---|---|---|
EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 13.04.2023 |
Ehemalige bekannte Positionen von James Vollins
Unternehmen | Position | Ende |
---|---|---|
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | 22.03.2022 |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Compliance Officer | 01.10.2018 |
Ausbildung von James Vollins
Wesleyan University | Undergraduate Degree |
Case Western Reserve University School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Health Technology |